4,5-Dimethyl-4H-1,2,4-triazol-3-amine hydroiodide, 97%, 500mg

9-Ethynyl-9-fluorenol, 98.0%, 25g

(CYCLOPROPYLMETHOXY)ACETIC ACID, 95.0%, 250mg

4-(Bromomethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 25g

3-(5-methyl-1H-tetrazol-1-yl)propanoic acid, 95.0%, 1g

Méthylcyclohexane, min 99 %, pour la synthèse, 25 l, avec bl.

Methyl 2-(chloromethyl)acrylate, 95.0%, 1g

CYCLOPENTANECARBONITRILE, 95.0%, 1g

3-BENZYL-6-OXA-3-AZA-BICYCLO[3.1.0]HEXANE, 95.0%, 100mg

(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid, 98%, 25mg

1-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-yl)-[1,4]diazepane hydrochloride, 95.0%, 100mg

trans-4-Methoxyphenyl 4-pentylcyclohexanecarboxylate, 95%, 25g

Unité de filtration Rapid-Flow avec membrane PES Taille des pores 0,1 μm, 1000 ml, 1000 ml, 90 mm, 12 pièce(s)